Target CTA and prospective CTA | Bolus tracking | Effective dose (mSv) |
Phantom study (TLD and Alderson) | Phantom study (TLD and Alderson) | 5.28 |
k-factorICRP 0.0140 | k-factorICRP 0.0140 | 2.57 |
k-factorICRP 0.0140 | k-factorImPACT 0.0410 | 2.64 |
k-factorImPACT 0.0285 | k-factorImPACT 0.0410 | 5.26 |